|
|
|
41
|
57811
|
AVODART 0.5MG CAP (GSK) DUTASTERIDE (C)
|
DUTASTERIDE
|
AVODART
|
30'S
|
C
|
90.06
|
3.0019
|
CAP
|
0
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
5 ALPHA REDUCTASE INHIBITORS
|
|
|
|
|
42
|
57811
|
AVODART 0.5MG CAP (GSK) DUTASTERIDE
|
DUTASTERIDE
|
AVODART
|
30'S
|
C
|
99.08
|
3.30
|
CAP
|
0
|
BLIS
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
5 ALPHA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
5781D
|
DUTASTERIDE 0.5MG CAP (CHC/ATB)
|
DUTASTERIDE
|
DUTASTERIDE
|
30'S
|
C
|
3.70
|
0.12
|
CAPSULE
|
0
|
CAP
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
5781E
|
APO-DUTASTERIDE 0.5MG TAB (APO) (C)
|
DUTASTERIDE
|
APO-DUTASTERIDE
|
30'S
|
C
|
15.63
|
0.521
|
TAB
|
0
|
BOX
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
5 ALPHA REDUCTASE INHIBITORS
|
|
|
|
|
42
|
5781G
|
ALFATAM 0.5MG CAP (ZYD) DUTASTERIDE
|
DUTASTERIDE
|
ALFATAM
|
30'S
|
C
|
11.09
|
0.37
|
CAP
|
0
|
BOTT
|
ZYD
|
ZYDUS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
5 ALPHA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
57822
|
DUODART 0.5MG | 0.4MG TAB (GSK/COL) DUTASTERIDE
|
DUTASTERIDE|TAMSULOSIN
|
DUODART
|
30'S
|
C
|
73.48
|
2.45
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
57822
|
DUODART 0.5MG|0.4MG TAB (GSK) DUTASTERIDE|TAMSULOSIN MR (C)
|
DUTASTERIDE|TAMSULOSIN MR
|
DUODART
|
30'S
|
C
|
88.18
|
2.9394
|
TAB
|
0
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
5 ALPHA REDUCTASE INHIBITORS
|
|
|
|
|
42
|
57822
|
DUODART 0.5MG|0.4MG TAB (GSK) DUTASTERIDE|TAMSULOSIN MR
|
DUTASTERIDE|TAMSULOSIN
|
DUODART
|
30'S
|
C
|
96.99
|
3.23
|
TAB
|
0
|
BLIS
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
5 ALPHA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
57828
|
DUTASTERIDE | TAMSULOSIN 0.5MG | 0.4MG TAB (CHC/ATB)
|
DUTASTERIDE|TAMSULOSIN
|
DUTASTERIDE|TAMSULOSIN
|
30'S
|
BQ
|
4.89
|
0.16
|
TABLET
|
0
|
TAB
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
41
|
57829
|
TRUVERA 0.5MG|0.4MG CAP (TMP) DUTASTERIDE|TAMSULOSIN MR (C)
|
DUTASTERIDE|TAMSULOSIN MR
|
TRUVERA
|
3X10
|
C
|
23.89
|
0.7965
|
CAP
|
0
|
BOX
|
TMP
|
THE MADRAS PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
5 ALPHA REDUCTASE INHIBITORS
|
|
|
|
|
42
|
5782A
|
DUTASTERIDE|TAMSULOSIN 0.5MG|0.4MG CAP (ZHL)
|
DUTASTERIDE|TAMSULOSIN
|
DUTASTERIDE|TAMSULOSIN
|
3X10
|
C
|
11.96
|
0.40
|
CAP
|
0
|
BLIS
|
ZHL
|
ZENITH HEALTHCARE LIMITED
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
9208
|
5 ALPHA REDUCTASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
0
|
5 ALPHA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
58022
|
IMMUNINE 600IU INJ (BAX/STO) FACTOR IX
|
FACTOR IX
|
IMMUNINE
|
600IU VIAL
|
BQ
|
608.58
|
608.58
|
INJECTION
|
0
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
202816
|
HEMOSTATICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
58022
|
IMMUNINE 600IU INJ (BAX) FACTOR IX
|
FACTOR IX
|
IMMUNINE
|
600IU VIAL
|
BQ
|
634.35
|
634.3481
|
VIAL
|
0
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
202816
|
HEMOSTATICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
HEMOSTATICS
|
|
|
|
|
42
|
58022
|
IMMUNINE 600IU INJ (BAX) FACTOR IX
|
FACTOR IX
|
IMMUNINE
|
600IU VIAL
|
BQ
|
634.35
|
634.35
|
VIAL
|
0
|
VIAL
|
BAX
|
BAXTER EXPORT CORP.
|
STO
|
BRYDEN STOKES LTD
|
|
202816
|
HEMOSTATICS
|
2026-04-01
|
|
|
IV
|
0
|
HEMOSTATICS
|
|
|
|
|
42
|
58027
|
FACTORCEL IX 600IU INJ (INP) FACTOR IX
|
FACTOR IX
|
FACTORCEL IX
|
600IU VIAL
|
BQ
|
951.71
|
951.71
|
VIAL
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2016
|
HEMATOPOIETIC
|
2026-04-01
|
|
|
IV
|
0
|
HEMATOPOIETIC
|
|
|
|
|
40
|
5811BA
|
APO-VERAP 120MG TAB (APO/COL)
|
VERAPAMIL
|
APO-VERAP
|
100'S
|
A
|
21.88
|
0.22
|
TABLET
|
60
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
242892
|
CCBs, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
42
|
5811BA
|
APO-VERAP 120MG TAB (APO)
|
VERAPAMIL
|
APO-VERAP
|
100'S
|
A
|
22.32
|
0.22
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
B
|
242892
|
CCBs, MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
6
|
CCBs, MISCELLANEOUS
|
|
|
|
|
40
|
5811CQ
|
ISOPTIN 80MG TAB (ABB/PHA) VERAPAMIL
|
VERAPAMIL
|
ISOPTIN
|
50'S
|
C
|
8.62
|
0.17
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
242892
|
CCBs, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
5811CQ
|
ISOPTIN 80MG TAB (ABB/PHA) VERAPAMIL (C)
|
VERAPAMIL
|
ISOPTIN
|
50'S
|
C
|
8.62
|
0.1724
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
242892
|
CCBs, MISCELLANEOUS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
0
|
CCBs, MISCELLANEOUS
|
2023-03-02
|
|
|
|
40
|
5811CW
|
AMLODIPINE 10MG TAB (HEA/RXP)
|
AMLODIPINE
|
AMLODIPINE
|
10X10
|
A
|
2.36
|
0.02
|
TABLET
|
30
|
TAB
|
HEA
|
HEALTH 2000 INC
|
RXP
|
RX PRO INC
|
B
|
242808
|
DIHYDROPYRIDINES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
